Gao W - Search Results

1

A nanomedicine based combination therapy based on QLPVM peptide functionalized liposomal tamoxifen and doxorubicin against Luminal A breast cancer.

Wang X, Chen X, Yang X, Gao W, He B, Dai W, Zhang H, Wang X, Wang J, Zhang X, Dai Z, Zhang Q. Wang X, et al. Among authors: gao w. Nanomedicine. 2016 Feb;12(2):387-97. doi: 10.1016/j.nano.2015.12.360. Epub 2015 Dec 19. Nanomedicine. 2016. PMID: 26711969

2

Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage.

Shi NQ, Gao W, Xiang B, Qi XR. Shi NQ, et al. Among authors: gao w. Int J Nanomedicine. 2012;7:1613-21. doi: 10.2147/IJN.S30104. Epub 2012 Mar 26. Int J Nanomedicine. 2012. PMID: 22619516 Free PMC article.

3

Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.

Gao W, Xiang B, Meng TT, Liu F, Qi XR. Gao W, et al. Biomaterials. 2013 May;34(16):4137-4149. doi: 10.1016/j.biomaterials.2013.02.014. Epub 2013 Mar 1. Biomaterials. 2013. PMID: 23453200

4

pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.

Dong DW, Xiang B, Gao W, Yang ZZ, Li JQ, Qi XR. Dong DW, et al. Among authors: gao w. Biomaterials. 2013 Jul;34(20):4849-59. doi: 10.1016/j.biomaterials.2013.03.018. Epub 2013 Mar 27. Biomaterials. 2013. PMID: 23541420

5

Hydrophobic penetrating peptide PFVYLI-modified stealth liposomes for doxorubicin delivery in breast cancer therapy.

Cai D, Gao W, He B, Dai W, Zhang H, Wang X, Wang J, Zhang X, Zhang Q. Cai D, et al. Among authors: gao w. Biomaterials. 2014 Feb;35(7):2283-94. doi: 10.1016/j.biomaterials.2013.11.088. Epub 2013 Dec 19. Biomaterials. 2014. PMID: 24360410

6

Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: High drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity.

Lin Z, Gao W, Hu H, Ma K, He B, Dai W, Wang X, Wang J, Zhang X, Zhang Q. Lin Z, et al. Among authors: gao w. J Control Release. 2014 Jan 28;174:161-70. doi: 10.1016/j.jconrel.2013.10.026. J Control Release. 2014. PMID: 24512789

7

The co-delivery of a low-dose P-glycoprotein inhibitor with doxorubicin sterically stabilized liposomes against breast cancer with low P-glycoprotein expression.

Gao W, Lin Z, Chen M, Yang X, Cui Z, Zhang X, Yuan L, Zhang Q. Gao W, et al. Int J Nanomedicine. 2014 Jul 21;9:3425-37. doi: 10.2147/IJN.S56070. eCollection 2014. Int J Nanomedicine. 2014. PMID: 25092974 Free PMC article.

8

The use of α-conotoxin ImI to actualize the targeted delivery of paclitaxel micelles to α7 nAChR-overexpressing breast cancer.

Mei D, Lin Z, Fu J, He B, Gao W, Ma L, Dai W, Zhang H, Wang X, Wang J, Zhang X, Lu W, Zhou D, Zhang Q. Mei D, et al. Among authors: gao w. Biomaterials. 2015 Feb;42:52-65. doi: 10.1016/j.biomaterials.2014.11.044. Epub 2014 Dec 13. Biomaterials. 2015. PMID: 25542793

9

Therapeutic potential of targeted multifunctional nanocomplex co-delivery of siRNA and low-dose doxorubicin in breast cancer.

Dong D, Gao W, Liu Y, Qi XR. Dong D, et al. Among authors: gao w. Cancer Lett. 2015 Apr 10;359(2):178-86. doi: 10.1016/j.canlet.2015.01.011. Epub 2015 Jan 12. Cancer Lett. 2015. PMID: 25592040

10

A folate modified pH sensitive targeted polymeric micelle alleviated systemic toxicity of doxorubicin (DOX) in multi-drug resistant tumor bearing mice.

Li X, Yang X, Lin Z, Wang D, Mei D, He B, Wang X, Wang X, Zhang Q, Gao W. Li X, et al. Among authors: gao w. Eur J Pharm Sci. 2015 Aug 30;76:95-101. doi: 10.1016/j.ejps.2015.04.018. Epub 2015 Apr 25. Eur J Pharm Sci. 2015. PMID: 25917524

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,877 results

Search Page

Filters